An alkali-insoluble fraction 1 (F1), which contains mainly ß-glucan isolated from the cell wall of Histoplasma capsulatum, induces eosinophil recruitment into the peritoneal cavity of mice. The present study was carried out to determine the participation of interleukin-5 (IL-5) in this process. Inbred C57BL/6 male mice weighing 15-20 g were treated ip with 100 µg of anti-IL-5 monoclonal antibody (TRFK-5, N = 7) or an isotype-matched antibody (N = 7), followed by 300 µg F1 in 1 ml PBS ip 24 h later. Controls (N = 5) received only 1 ml PBS. Two days later, cells from the peritoneal cavity were harvested by injection of 3 ml PBS and total cell counts were determined using diluting fluid in a Neubauer chamber. Differential counts were performed using Rosenfeld-stained cytospin preparations. The F1 injection induced significant (P < 0.01) leukocyte recruitment into the peritoneal cavity (8.4 x 10 6 cells/ml) when compared with PBS alone (5.5 x 10 6 cells/ ml). Moreover, F1 selectively (P < 0.01) induced eosinophil recruitment (1 x 10 6 cells/ml) when compared to the control group (0.07 x 10 6 cells/ml). Treatment with TRFK-5 significantly (P < 0.01) inhibited eosinophil recruitment (0.18 x 10 6 cells/ml) by F1 without affecting recruitment of mononuclear cells or neutrophils. We conclude that the F1 fraction of the cell wall of H. capsulatum induces peritoneal eosinophilia by an IL-5-dependent mechanism. Depletion of this cytokine does not have effect on the recruitment of other cell types induced by F1.
The eosinophil granulocyte, although probably first observed by Warton Jones in 1846 in unstained preparations of peripheral blood, was so named by Paul Erlich in 1879 because of the intense staining of its granules with the acidic dye eosin (1) . Eosinophils have been the subject of extensive investigation since then and their occurrence is observed mainly in parasite infections and in the late phase of immediate hypersensitivity reactions (2, 3) . For several years we have investigated the mechanisms involved in eosinophil recruitment. We have developed and studied a system to measure the accumulation of radiolabeled 111 In-eosinophils in guinea pig skin in vivo (4) . Using this same method, we have demonstrated the eosinophil chemoattractant activity of interleukin-8 (IL-8) (5) and eosinophil accumulation induced by LPS (6) . More recently we have investigated the factors involved in eosinophil migration in different experimental models of eosinophilia. Using a murine model of toxocariasis, a nematode infection, we demonstrated the role of IL-5 in driving eosinophils from bone marrow to blood and tissues and in modulating IL-8 production in eosinophilic inflammation (7, 8) . In addition, we demonstrated that leukotrienes play a role in the leukocyte recruitment to the peritoneal cavity induced by the alkali-insoluble fraction 1 (F1), which contains mainly ß-glucan, from the cell wall of Histoplasma capsulatum, a dimorphic pathogenic fungus (9) . In the present study we investigated the participation of IL-5 in eosinophil recruitment to the peritoneal cavity induced by the F1 cell wall fraction of H. capsulatum.
All experiments were approved and conducted in accordance with the guidelines of the Animal Care Committee of the University.
Inbred C57BL/6 male mice weighing 15-20 g were purchased from the animal house of the Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil, and were maintained under standard laboratory conditions. The F1 polysaccharide of H. capsulatum was prepared as described (10) . Briefly, yeast forms of the fungus were cultured at 37ºC in BHI-agar medium (Difco Laboratories, Sparks, MD, USA) and supplemented with 5% sheep blood for 15 days. Yeasts were harvested, formalin-killed and washed several times with distilled water. The cell walls of the dead yeast were disrupted by ultrasonic vibration and washed three times with distilled water by centrifugation at 5000 g for 5 min. Lipids were extracted by repeated soaking of the walls in chloroform/methanol (2:1, v/v) at room temperature for 2 h with shaking. The extracts were separated by centrifugation at 5000 g for 5 min and the insoluble residue was extracted three more times as described above. The resulting insoluble cell wall residue was suspended in 1 N NaOH and gently stirred at room temperature for 1 h. After centrifugation at 5000 g for 10 min, the supernatants were collected and the procedure was repeated four times. The alkali-insoluble sediment was washed with ethanol followed by acetone and diethyl ether. After drying, the resulting white powder was designated as F1 from the dead yeast form of H. capsulatum.
In order to induce leukocyte recruitment into the peritoneal cavity, 300 µg F1 was suspended in 1 ml PBS and was injected ip in mice (N = 14). Control mice received only 1 ml PBS (N = 5). This protocol induces timedependent leukocyte migration with characteristic kinetics among neutrophils, eosinophils, and mononuclear cells (9) . Twentyfour hours prior to F1 injection, one group of mice (N = 7) received an ip injection of 100 µg TRFK-5, an anti-IL-5 monoclonal antibody (mAb), and the other group (N = 7) received an isotype-matched mAb. This treatment was given in order to determine the participation of IL-5 in eosinophil recruitment. Forty-eight hours after F1 injection the animals were sacrificed by excess anesthesia because 48 h corresponds to the peak of eosinophil recruitment in this model (9) . Cells from the peritoneal cavities were harvested by injection of 3 ml PBS containing 5 U/ml heparin. The abdomens were gently massaged and a blood-free cell suspension was carefully withdrawn with a syringe. Abdominal washings were placed in plastic tubes and total cell counts were performed immediately in a Neubauer chamber. Differential counts were obtained using Rosenfeldstained cytospin preparations (7). Statistical differences were analyzed by the Student ttest. Two-way ANOVA was used to calculate the differences of significance among the groups. A P < 0.05 value was considered to be statistically significant.
The response of mice to ip administration of F1 after 48 h was the recruitment of 8.4 ± 1.25 x 10 6 cells/ml compared to 5.5 ± 0.31 x 10 6 cells/ml obtained with PBS (P < 0.01). The numbers of neutrophils, eosinophils, and mononuclear cells after F1 injection were also determined and the effect of TRFK-5 on the recruitment of these cells is shown in Figure 1 . No differences in mononuclear cell counts were observed between control mice and mice injected with F1, who were treated with either TRFK-5 or with the isotype antibody ( Figure 1C) . However, F1 induced significantly greater (P < 0.01) neutrophil recruitment (4.4 x 10 5 cells/ml) when compared to PBS (0.6 x 10 5 cells/ml). Treatment of mice with TRFK-5 increased neutrophil recruitment induced by F1 ( Figure  1B ). In addition, eosinophil recruitment by F1 (1 x 10 6 cells/ml) was 14-fold higher (P < 0.01) compared to the PBS control group (0.07 x 10 6 cells/ml). Treatment with TRFK-5 significantly (P < 0.01) inhibited eosinophil recruitment into the peritoneal cavity by more than 80% ( Figure 1A) .
Both granulocyte-macrophage colonystimulation factor and IL-3 stimulate the recruitment of eosinophils as well as other leukocytes, whereas IL-5 specifically supports the terminal differentiation and proliferation of eosinophil precursors as well as the eosinophil activation effect (11) (12) (13) . Several chemoattractants are involved in both in vitro and in vivo eosinophil migration. Many investigators have demonstrated a direct correlation between eosinophilia and IL-5 in human helminth infection and in experimental animal models. It has also been demonstrated that anti-IL-5 mAb treatment inhibits eosinophilia in mice infected with Toxocara canis, Nippostrongylus brasiliensis and Schistosoma mansoni (14) (15) (16) . In addition, IL-5 plays an important role in mobilizing eosinophils from bone marrow to peripheral blood and in priming eosinophils to respond easily to other chemotactic stimuli such as chemokines and lipid mediators (7, 17) . When a low dose of IL-5 is administered intravenously, it rapidly and dramatically enhances the eosinophil accumulation induced by intradermally injected eotaxin and leukotriene B 4 (17) , suggesting a link between chemoattractant factors and IL-5. It has been demonstrated that the chemotactic activity of eosinophils in bronchoalveolar lavage fluid obtained from rats infected with T. canis was significantly reduced after treatment with either a specific leukotriene B 4 receptor antagonist (ONO-4057), a platelet aggregating factor receptor antagonist (TCV-309), and an anti-IL-5 mAb (TB13) (18) . This suggests that these three factors contribute to the accumulation of eosinophils in the lungs of rats infected with T. canis. More recently, it was shown that antigen-induced eosinophilia in the lung is indirectly dependent on cysteinyl leukotrienes through IL-5 production in a model of late asthmatic response (19) . We (8) . Probably the same phenomena occurred in F1 TRFK-5-treated mice. The decrease in IL-5 by TRFK-5 treatment should up-regulate the KC chemokine (murine IL-8) levels, and F1 should recruit more neutrophils to the peritoneal cavity, since this molecule is chemotactic for neutrophils (20) .
Finally, in the present study we demonstrated that F1-induced eosinophil recruitment, but not the recruitment of other cell types, is IL-5-dependent within a specific time window, i.e., 48 h after F1 injection. We suggest that the eosinophil recruitment induced by ip injection of F1 is mediated by an interaction between at least two eosinophilic mediators, leukotrienes and IL-5.
